Biosero, a developer of integrated laboratory automation solutions, has received the first purchase orders for 15.2 MUSD from a global pharma company. The project will involve developing integrated lab solutions to support the customers drug development process. The initial revenue will be split between labor and software, with the remainder expected to be evenly distributed throughout 2026. The purchase orders are part of a multi-year master service agreement between Biosero and the customer.
Source
This post was brought to you by Wrk. Our bot looks for news related to automation and post daily.
